TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Cypromed AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
3,984
|
3,668
|
3,412 |
| Financial expenses |
18
|
12
|
5 |
| Earnings before taxes |
533
|
576
|
563 |
| Total assets |
2,073
|
2,332
|
1,999 |
| Current assets |
1,867
|
2,266
|
1,929 |
| Current liabilities |
1,267
|
1,552
|
1,252 |
| Equity capital |
806
|
780
|
747 |
| - share capital |
47
|
50
|
53 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
38.9%
|
33.4%
|
37.4% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
13.4%
|
15.7%
|
16.5% |
| Return on assets (ROA) |
26.6%
|
25.2%
|
28.4% |
| Current ratio |
147.4%
|
146.0%
|
154.1% |
| Return on equity (ROE) |
66.1%
|
73.8%
|
75.4% |
| Change turnover |
503
|
473
|
286 |
| Change turnover % |
14%
|
15%
|
9% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.